ACHE and Alzheimer disease: In fact, three out of the four approved single drugs work by increasing the lifespan of ACh by inhibiting the enzyme acetylcholinesterase (AChE), which is mainly responsible for metabolizing Ach, and has been recognized as the most effective drug target for developing AD drugs [162].